Palatin Technologies
PTN
$1.82
Share price
5.81%
Change (1 day)
-22.88%
Change (1 year)
Categories
Palatin Technologies (PTN) - Net assets
Net assets on the balance sheet as of December 2023 : -$11.39 M
According to Palatin Technologies's latest financial reports the company has -$11.39 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Palatin Technologies - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-06-30 | $0.13 M | -99.18% |
| 2022-06-30 | $16.26 M | -67.24% |
| 2021-06-30 | $49.65 M | -38.07% |
| 2020-06-30 | $80.17 M | -20.27% |
| 2019-06-30 | $0.10 B | 272.89% |
| 2018-06-30 | $26.96 M | -622.11% |
| 2017-06-30 | $-5.17 M | -70.63% |
| 2016-06-30 | $-17.59 M | -244.09% |
| 2015-06-30 | $12.2 M | 24.68% |
| 2014-06-30 | $9.78 M | -57.4% |
| 2013-06-30 | $22.97 M | 1155.03% |
| 2012-06-30 | $1.83 M | -89.94% |
| 2011-06-30 | $18.19 M | 95.23% |
| 2010-06-30 | $9.31 M | 181.22% |
| 2009-06-30 | $3.31 M | -49.43% |
| 2008-06-30 | $6.55 M | -64.64% |
| 2007-06-30 | $18.53 M | 1.27% |
| 2006-06-30 | $18.29 M | 98.37% |
| 2005-06-30 | $9.22 M | -52.41% |
| 2004-06-30 | $19.38 M | 3.91% |
| 2003-06-30 | $18.65 M | 114.77% |
| 2002-06-30 | $8.68 M | -27.1% |
| 2001-06-30 | $11.91 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -604,207.38% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | -329,506.91% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $2.23 B | -19,705.78% | 🇺🇸 USA |
 MediciNova MNOV | $62.37 M | -647.93% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.70 B | -6,256.78% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.45 B | -4,119.53% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $46.54 M | -508.87% | 🇺🇸 USA |
 Ardelyx ARDX | $0.16 B | -1,565.30% | 🇺🇸 USA |